Cytokines, bone turnover markers and weight change in candidates for lung transplantation

• Published in: Pulmonary pharmacology & therapeutics 2008-01, Vol.21 (1), p.188-195
• Main Authors: Førli, L, Mellbye, O.J, Halse, J, Bjørtuft, Ø, Vatn, M, Boe, J
• Format: Article
• Language: English
• Subjects: Adult; Anti-Inflammatory Agents - adverse effects; Biomarkers - blood; Body Weight; Bone Density; Bone Diseases, Metabolic - physiopathology; Bone markers; Bone resorption; C-Reactive Protein - analysis; Chronic obstructive pulmonary disease; Cross-Sectional Studies; Cytokines; Cytokines - blood; Female; Humans; Lung Diseases, Interstitial - physiopathology; Lung Transplantation; Male; Medical Education; Middle Aged; Prednisolone - adverse effects; Pulmonary disease; Pulmonary/Respiratory; Tumor necrosis factor; Weight loss
• ISSN: 1094-5539; 1522-9629
• DOI: 10.1016/j.pupt.2007.02.002

Abstract Weight loss in chronic obstructive pulmonary disease (COPD) is associated with increased morbidity and may negatively affect bone mineral density. Increased serum levels of cytokines such as tumour necrosis factor (TNF)- α have been associated with weight loss and with bone resorption. We studied the association between systemic inflammation, markers for bone turnover and recent weight change in underweight ( n =48) and normal-weight patients ( n =23) candidates for lung transplantation where the majority (56%) had COPD. Osteoporosis or osteopenia was present in all the diagnostic groups. The resulting model of linear regression in COPD patients showed that for the 1-CTP (a marker of bone resorption) model, the total variation of 61% was explained by recent weight change, sTNF- α receptor(R)II, dose of prednisolon and age. The resulting model of linear regression in the whole group of patients showed that the total variation of 72% was explained by recent weight change, sTNF- α RI, diagnosis (COPD/other diagnosis), dose of prednisolon and C-reactive protein. In conclusion, our results showed that serum concentration of 1-CTP was positively associated with sTNF- α receptor II and negatively with recent weight change in patients with advanced COPD. Recent weight loss in both the underweight and normal-weight patients showed to be a more important contributor than recent weight loss only in underweight patients for explaining variations in 1-CTP.